drugset / Trial / NCT00190918
A Trial for Patients With Gestational Trophoblastic Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This phase II study is evaluating the activity of Pemetrexed in patients diagnosed with low risk Gestational Trophoblastic Tumor (GTT) that have failed prior treatment.
Timeline
- Start
- 2006-07
- Primary completion
- —
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pemetrexed | Small molecule | — | — |